Clinical Trial: Assessment of Response and Safety of Bulevirtide Treatment in Patients With Chronic Delta Virus Infection

U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07116044) titled 'Assessment of Response and Safety of Bulevirtide Treatment in Patients With Chronic Delta Virus Infection' on Aug. 04.

Brief Summary: 1. The study is non-interventional, multicenter, non-profit

2. The primary objective of the study is to evaluate the safety and efficacy in clinical practice of the drug Bulevirtide in the treatment of patients with chronic HDV hepatitis. The drug is already approved and indicated in the treatment of patients with the aforementioned infectious pathology.

3. The Coordinating Center and the Principal Investigator of the study in question will be, respectively, the Department of Medical Health Sciences...